Brumm Joshua T — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Brumm Joshua T has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $761K.

Profile

Brumm Joshua T is identified in SEC filing contexts as the Chief Executive Officer of Crescent Biopharma, Inc. as of June 23, 2026. Beyond this role, no additional verified biographical details were provided in the SEC filings snippet or in the context you supplied. This response reflects publicly known information derived from the SEC context.

Board memberships

• Crescent Biopharma, Inc.

Awards & honors

• CEO of Crescent Biopharma, Inc. as of 2026-06-23 per SEC filing

Recent Transactions

Companies — Last 90 Days

• CRESCENT BIOPHARMA, INC. (CBIO) — 1 filings, last 2026-06-23

Frequently Asked Questions

Who is Brumm Joshua T?

Brumm Joshua T is identified in SEC filing contexts as the Chief Executive Officer of Crescent Biopharma, Inc. as of June 23, 2026. Beyond this role, no additional verified biographical details were provided in the SEC filings snippet or in the context you supplied. This response reflects publicly known information derived from the SEC context.…

How many SEC Form 4 filings has Brumm Joshua T submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Brumm Joshua T been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($761K) across all tracked filings.

Where can I see all of Brumm Joshua T's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week